Metformin HCL ER
Closed Solicitation Posted
- Solicitation number
- SPE2D219R0033
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- DLA Troop Support 700 Robbins Avenue Philadelphia PA 19111 USA
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency plans to issue a solicitation seeking a national requirements contract for metformin hydrochloride extended release tablets. The solicitation will provide for a one-year base period and four one-year option periods and will utilize firm-fixed pricing for the supply of metformin HCL ER tablets in bottle counts of 90, 100, 180, 360, 500, and 1000, as well as 750mg tablets in bottle counts of 90, 100, 180, and 500 or 1000. The contract is intended to establish a supply source for the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through DLA and VA prime vendor programs. Interested offerors should monitor the DLA Bid Board System and FEDBIZOPS for solicitation number SPE2D219R0033 projected to be posted in October 2018 and direct any questions to the point of contact provided.
The acquisition will be conducted as a fully competitive commercial item procurement under FAR Part 12 with no set-aside designations. Annual usage estimates will be included in the solicitation Schedule of Supplies. The projected place of performance will be the Defense Logistics Agency location in Philadelphia, Pennsylvania. Interested parties are advised to monitor the solicitation for additional details on technical requirements, past performance considerations, and evaluation criteria.
Notice text
2 versions
Update #2 · Latest ·
Metformin HCL ER
Update #1 ·
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Metformin HCL ER. Procurement details follow.
Metformin HCL ER Tablets 500MG in 90, 100, 180, 360 and 500 or 1000 count bottles; 750MG in 90, 100, 180 and 500 or 1000 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and FEDBIZOPS at https://www.fbo.gov. Interested parties should contact Joan Marie Grace (215-737-2663) (joanmarie.grace@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is October of 2018. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Files
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity